These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19698583)

  • 21. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of venlafaxine for the treatment of major depression in hospitalized patients.
    Priest RG
    Clin Ther; 1996; 18(2):347-58; discussion 302. PubMed ID: 8733994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
    Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
    Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early onset of antidepressant action of venlafaxine: pattern analysis in intent-to-treat patients.
    Entsuah R; Derivan A; Kikta D
    Clin Ther; 1998; 20(3):517-26. PubMed ID: 9663367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current treatment options: relief of symptoms and ultimate recovery.
    Kennedy SH
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():22-6. PubMed ID: 24931540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early onset of therapeutic action in depression and greater efficacy of antidepressant treatments: are they related?
    Blier P; Bergeron R
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S21-8. PubMed ID: 9347389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors.
    Rudolph RL
    Acta Psychiatr Scand Suppl; 2002; (415):24-30. PubMed ID: 12492770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique mechanism of action for escitalopram: does it hold the promise?
    Kasper S
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():15-8. PubMed ID: 24930684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
    Mukai Y; Tampi RR
    Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venlafaxine exhibits pre-clinical antidepressant activity in the resident-intruder social interaction paradigm.
    Mitchell PJ; Fletcher A
    Neuropharmacology; 1993 Oct; 32(10):1001-9. PubMed ID: 8295710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
    Shelton C; Entsuah R; Padmanabhan SK; Vinall PE
    Int Clin Psychopharmacol; 2005 Jul; 20(4):233-8. PubMed ID: 15933485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies.
    Invernizzi RW; Garattini S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):819-27. PubMed ID: 15363606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duloxetine: a review of its use in the treatment of major depressive disorder.
    Frampton JE; Plosker GL
    CNS Drugs; 2007; 21(7):581-609. PubMed ID: 17579500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
    van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.